Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer

Summary Total thyroidectomy, radioiodine (RAI) therapy, and TSH suppression are the mainstay treatment for differentiated thyroid carcinomas (DTCs). Treatments for metastatic disease include surgery, external-beam radiotherapy, RAI, and kinase inhibitors for progressive iodine-refractory disease. Un...

Full description

Bibliographic Details
Main Authors: Debora L. S. Danilovic, Gilberto Castro Jr., Felipe S. R. Roitberg, Felipe A. B. Vanderlei, Fernanda A. Bonani, Ricardo M. C. Freitas, George B. Coura-Filho, Rosalinda Y. Camargo, Marco A. Kulcsar, Suemi Marui, Ana O. Hoff
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2018-05-01
Series:Archives of Endocrinology and Metabolism
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000300370&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000300370&lng=en&tlng=en

Similar Items